ID

16328

Beschreibung

Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow; ODM derived from: https://clinicaltrials.gov/show/NCT00248703

Link

https://clinicaltrials.gov/show/NCT00248703

Stichworte

Versionen (1)
  1. 11.07.16 11.07.16 -
Hochgeladen am

11. Juli 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00248703

Englisch

Eligibility Breast Cancer NCT00248703

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. breast cancer with node positive disease or high risk node negative disease (pt1c/t2gii-iiin0, pt3n0, ct3n0). patients < 35 years with pt1a-bn0g2-3.
Beschreibung

Breast Carcinoma | Disease lymph node positive | Disease Negative Lymph Node High risk | TNM clinical staging | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0746319
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0678034
UMLS CUI [3,3]
C0332167
UMLS CUI [4]
C3258246
UMLS CUI [5]
C0001779
2. primary surgery for breast cancer completed
Beschreibung

Breast Carcinoma Operative Surgical Procedure Primary Complete

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0543467
UMLS CUI [1,3]
C0205225
UMLS CUI [1,4]
C0205197
3. completed 6 cycles of adjuvant (or neoadjuvant) chemotherapy containing anthracycline
Beschreibung

Adjuvant Chemotherapy Containing Anthracyclines | Neoadjuvant Chemotherapy Containing Anthracyclines

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0085533
UMLS CUI [1,2]
C0332256
UMLS CUI [1,3]
C0282564
UMLS CUI [2,1]
C0600558
UMLS CUI [2,2]
C0392920
UMLS CUI [2,3]
C0332256
UMLS CUI [2,4]
C0282564
4. age ≥ 18 and < 70 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
5. eastern cooperative oncology group or who performance status < 2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
6. written informed consent prior to beginning protocol specific procedures
Beschreibung

Informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
7. laboratory requirements (within 5 weeks prior to end of radiation treatment or within 5 weeks prior to completion of baseline examinations):
Beschreibung

Laboratory Procedures Requirement | Therapeutic radiology procedure | Physical Examination

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C1514873
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0031809
neutrophils ≥ 1.1 10^9/l, platelets ≥ 100 10^9/l, hemoglobin ≥ 10 g/dl, asat and alat ≤ x 2.5 unl (if alp > 2.5 ≤ x 5 unl, then asat and alat ≤ x 1.5 unl), alp ≤ x 5 unl (if asat and alat > 1.5 ≤ x 2.5 unl, then alp ≤ 2.5 x unl), creatinine ≤ 175 umol/l
Beschreibung

Absolute neutrophil count | Blood Platelets | Hemoglobin | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement | Creatinine measurement, serum

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0005821
UMLS CUI [3]
C0019046
UMLS CUI [4]
C0201899
UMLS CUI [5]
C0201836
UMLS CUI [6]
C0201850
UMLS CUI [7]
C0201976
8. completed staging analysis including chest x-ray, bone scintigraphy or mri, liver ultrasound or liver ct scan
Beschreibung

Staging of disease Complete | Plain chest X-ray | Bone scintigraphy | Magnetic Resonance Imaging | Ultrasonography of liver | Computerized Tomography (CT Scan) of Liver

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0449385
UMLS CUI [1,2]
C0205197
UMLS CUI [2]
C0039985
UMLS CUI [3]
C3889015
UMLS CUI [4]
C0024485
UMLS CUI [5]
C0412534
UMLS CUI [6]
C2455874
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. other (than breast carcinoma) earlier or concomitant carcinoma, except for skin and in situ cervix cancer
Beschreibung

Carcinoma | Breast Carcinoma | Skin carcinoma | Carcinoma in situ of uterine cervix

Datentyp

boolean

Alias
UMLS CUI [1]
C0007097
UMLS CUI [2]
C0678222
UMLS CUI [3]
C0699893
UMLS CUI [4]
C0851140
2. m1 breast cancer or locoregional recurrence of previously diagnosed breast cancer.
Beschreibung

malignant neoplasm of breast M1 | Breast cancer recurrent Local-Regional

Datentyp

boolean

Alias
UMLS CUI [1]
C2216706
UMLS CUI [2,1]
C0278493
UMLS CUI [2,2]
C1947913
3. earlier treatment with paclitaxel or docetaxel.
Beschreibung

Paclitaxel | docetaxel

Datentyp

boolean

Alias
UMLS CUI [1]
C0144576
UMLS CUI [2]
C0246415
4. pre-existing motor or sensory neurotoxicity of a severity ≥ grade 2 by nci criteria (see appendix ii)
Beschreibung

Motor nerve Toxicity Pre-existing | Sensory nerve Toxicity Pre-existing | CTCAE

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0501384
UMLS CUI [1,2]
C0600688
UMLS CUI [1,3]
C2347662
UMLS CUI [2,1]
C0501385
UMLS CUI [2,2]
C0600688
UMLS CUI [2,3]
C2347662
UMLS CUI [3]
C1516728
5. cardiac disease with symptoms classified as nyha ≥ 2
Beschreibung

NYHA

Datentyp

boolean

Alias
UMLS CUI [1]
C1275491
6. definite contraindications for the use of corticosteroids
Beschreibung

Medical contraindication Adrenal Cortex Hormones

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0001617
7. concurrent treatment with other experimental drugs
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
8. concurrent treatment with any other anti-cancer therapy (except for endocrine therapy and trastuzumab)
Beschreibung

cancer treatment | Hormone Therapy | trastuzumab

Datentyp

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2]
C0279025
UMLS CUI [3]
C0728747
9. pregnancy
Beschreibung

Pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT00248703

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma | Disease lymph node positive | Disease Negative Lymph Node High risk | TNM clinical staging | Age
Item
1. breast cancer with node positive disease or high risk node negative disease (pt1c/t2gii-iiin0, pt3n0, ct3n0). patients < 35 years with pt1a-bn0g2-3.
boolean
C0678222 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C0746319 (UMLS CUI [2,2])
C0012634 (UMLS CUI [3,1])
C0678034 (UMLS CUI [3,2])
C0332167 (UMLS CUI [3,3])
C3258246 (UMLS CUI [4])
C0001779 (UMLS CUI [5])
Breast Carcinoma Operative Surgical Procedure Primary Complete
Item
2. primary surgery for breast cancer completed
boolean
C0678222 (UMLS CUI [1,1])
C0543467 (UMLS CUI [1,2])
C0205225 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,4])
Adjuvant Chemotherapy Containing Anthracyclines | Neoadjuvant Chemotherapy Containing Anthracyclines
Item
3. completed 6 cycles of adjuvant (or neoadjuvant) chemotherapy containing anthracycline
boolean
C0085533 (UMLS CUI [1,1])
C0332256 (UMLS CUI [1,2])
C0282564 (UMLS CUI [1,3])
C0600558 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C0332256 (UMLS CUI [2,3])
C0282564 (UMLS CUI [2,4])
Age
Item
4. age ≥ 18 and < 70 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
5. eastern cooperative oncology group or who performance status < 2
boolean
C1520224 (UMLS CUI [1])
Informed consent
Item
6. written informed consent prior to beginning protocol specific procedures
boolean
C0021430 (UMLS CUI [1])
Laboratory Procedures Requirement | Therapeutic radiology procedure | Physical Examination
Item
7. laboratory requirements (within 5 weeks prior to end of radiation treatment or within 5 weeks prior to completion of baseline examinations):
boolean
C0022885 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2])
C0031809 (UMLS CUI [3])
Absolute neutrophil count | Blood Platelets | Hemoglobin | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement | Creatinine measurement, serum
Item
neutrophils ≥ 1.1 10^9/l, platelets ≥ 100 10^9/l, hemoglobin ≥ 10 g/dl, asat and alat ≤ x 2.5 unl (if alp > 2.5 ≤ x 5 unl, then asat and alat ≤ x 1.5 unl), alp ≤ x 5 unl (if asat and alat > 1.5 ≤ x 2.5 unl, then alp ≤ 2.5 x unl), creatinine ≤ 175 umol/l
boolean
C0948762 (UMLS CUI [1])
C0005821 (UMLS CUI [2])
C0019046 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
C0201836 (UMLS CUI [5])
C0201850 (UMLS CUI [6])
C0201976 (UMLS CUI [7])
Staging of disease Complete | Plain chest X-ray | Bone scintigraphy | Magnetic Resonance Imaging | Ultrasonography of liver | Computerized Tomography (CT Scan) of Liver
Item
8. completed staging analysis including chest x-ray, bone scintigraphy or mri, liver ultrasound or liver ct scan
boolean
C0449385 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0039985 (UMLS CUI [2])
C3889015 (UMLS CUI [3])
C0024485 (UMLS CUI [4])
C0412534 (UMLS CUI [5])
C2455874 (UMLS CUI [6])
Item Group
C0680251 (UMLS CUI)
Carcinoma | Breast Carcinoma | Skin carcinoma | Carcinoma in situ of uterine cervix
Item
1. other (than breast carcinoma) earlier or concomitant carcinoma, except for skin and in situ cervix cancer
boolean
C0007097 (UMLS CUI [1])
C0678222 (UMLS CUI [2])
C0699893 (UMLS CUI [3])
C0851140 (UMLS CUI [4])
malignant neoplasm of breast M1 | Breast cancer recurrent Local-Regional
Item
2. m1 breast cancer or locoregional recurrence of previously diagnosed breast cancer.
boolean
C2216706 (UMLS CUI [1])
C0278493 (UMLS CUI [2,1])
C1947913 (UMLS CUI [2,2])
Paclitaxel | docetaxel
Item
3. earlier treatment with paclitaxel or docetaxel.
boolean
C0144576 (UMLS CUI [1])
C0246415 (UMLS CUI [2])
Motor nerve Toxicity Pre-existing | Sensory nerve Toxicity Pre-existing | CTCAE
Item
4. pre-existing motor or sensory neurotoxicity of a severity ≥ grade 2 by nci criteria (see appendix ii)
boolean
C0501384 (UMLS CUI [1,1])
C0600688 (UMLS CUI [1,2])
C2347662 (UMLS CUI [1,3])
C0501385 (UMLS CUI [2,1])
C0600688 (UMLS CUI [2,2])
C2347662 (UMLS CUI [2,3])
C1516728 (UMLS CUI [3])
NYHA
Item
5. cardiac disease with symptoms classified as nyha ≥ 2
boolean
C1275491 (UMLS CUI [1])
Medical contraindication Adrenal Cortex Hormones
Item
6. definite contraindications for the use of corticosteroids
boolean
C1301624 (UMLS CUI [1,1])
C0001617 (UMLS CUI [1,2])
Investigational New Drugs
Item
7. concurrent treatment with other experimental drugs
boolean
C0013230 (UMLS CUI [1])
cancer treatment | Hormone Therapy | trastuzumab
Item
8. concurrent treatment with any other anti-cancer therapy (except for endocrine therapy and trastuzumab)
boolean
C0920425 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
C0728747 (UMLS CUI [3])
Pregnancy
Item
9. pregnancy
boolean
C0032961 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video